These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 6886002

  • 1. "Fibrinogen Tokyo II". An abnormal fibrinogen with an impaired polymerization site on the aligned DD domain of fibrin molecules.
    Matsuda M, Baba M, Morimoto K, Nakamikawa C.
    J Clin Invest; 1983 Sep; 72(3):1034-41. PubMed ID: 6886002
    [Abstract] [Full Text] [Related]

  • 2. Fibrinogen Vicenza and Genova II: two new cases of congenital dysfibrinogenemia with isolated defect of fibrin monomer polymerization and inhibitory activity on normal coagulation.
    Rodeghiero F, Castaman GC, Dal Belin Peruffo A, Dini E, Galletti A, Barone E, Gastaldi G.
    Thromb Haemost; 1987 Jun 03; 57(3):252-8. PubMed ID: 2958952
    [Abstract] [Full Text] [Related]

  • 3. Fibrinogen St. Gallen I (gamma 292 Gly--> Val): evidence for structural alterations causing defective polymerization and fibrinogenolysis.
    Stucki B, Schmutz P, Schmid L, Haeberli A, Lämmle B, Furlan M.
    Thromb Haemost; 1999 Feb 03; 81(2):268-74. PubMed ID: 10064005
    [Abstract] [Full Text] [Related]

  • 4. Normal binding of calcium to five fibrinogen variants with mutations in the carboxy terminal part of the gamma-chain.
    Furlan M, Stucki B, Steinmann C, Jungo M, Lämmle B.
    Thromb Haemost; 1996 Sep 03; 76(3):377-83. PubMed ID: 8883274
    [Abstract] [Full Text] [Related]

  • 5. Binding of a new monoclonal antibody against N-terminal heptapeptide of fibrin alpha-chain to fibrin polymerization site 'A': effects of fibrinogen and fibrinogen derivatives, and pretreatment of samples with NaSCN.
    Dempfle CE, Dollman M, Lill H, Puzzovio D, Dessauer A, Heene DL.
    Blood Coagul Fibrinolysis; 1993 Feb 03; 4(1):79-86. PubMed ID: 8457657
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Fibrinogen Haifa: fibrinogen variant with absence of protective effect of calcium on plasmin degradation of gamma chains.
    Soria J, Soria C, Samama M, Tabori S, Kehl M, Henschen A, Nieuwenhuizen W, Rimon A, Tatarski I.
    Thromb Haemost; 1987 Jun 03; 57(3):310-3. PubMed ID: 2958955
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Heterozygous abnormal fibrinogen Osaka III with the replacement of gamma arginine-275 by histidine has an apparently higher molecular weight gamma-chain variant.
    Yoshida N, Imaoka S, Hirata H, Matsuda M, Asakura S.
    Thromb Haemost; 1992 Nov 10; 68(5):534-8. PubMed ID: 1455400
    [Abstract] [Full Text] [Related]

  • 12. The mutation in fibrinogen Bicêtre II (gamma Asn308-->Lys) does not affect the binding of t-PA and plasminogen to fibrin.
    Grailhe P, Boyer-Neumann C, Haverkate F, Grimbergen J, Larrieu MJ, Anglés-Cano E.
    Blood Coagul Fibrinolysis; 1993 Oct 10; 4(5):679-87. PubMed ID: 8292717
    [Abstract] [Full Text] [Related]

  • 13. Fibrinogen Milano II: a congenital dysfibrinogenaemia associated with juvenile arterial and venous thrombosis.
    Haverkate F, Koopman J, Kluft C, D'Angelo A, Cattaneo M, Mannucci PM.
    Thromb Haemost; 1986 Feb 28; 55(1):131-5. PubMed ID: 3705000
    [Abstract] [Full Text] [Related]

  • 14. The polymerization of fibrin prepared from fibrinogen Haifa (gamma 275Arg----His).
    Siebenlist KR, Mosesson MW, Di Orio JP, Tavori S, Tatarsky I, Rimon A.
    Thromb Haemost; 1989 Nov 24; 62(3):875-9. PubMed ID: 2512677
    [Abstract] [Full Text] [Related]

  • 15. [Familial dysfibrinogenemia with abnormal nonomer aggregation. Paris III fibrinogen].
    Soria J, Soria C.
    Pathol Biol (Paris); 1974 Nov 24; 22 suppl():72-9. PubMed ID: 4620099
    [No Abstract] [Full Text] [Related]

  • 16. Fibrinogen and fibrin polymerization: appraisal of the binding events that accompany fibrin generation and fibrin clot assembly.
    Mosesson MW.
    Blood Coagul Fibrinolysis; 1997 Jul 24; 8(5):257-67. PubMed ID: 9282789
    [Abstract] [Full Text] [Related]

  • 17. Dysfibrinogen Kagoshima with the amino acid substitution gammaThr-314 to Ile: analyses of molecular abnormalities and thrombophilic nature of this abnormal molecule.
    Niwa K, Mimuro J, Miyata M, Sugo T, Ohmori T, Madoiwa S, Tei C, Sakata Y.
    Thromb Res; 2008 Jul 24; 121(6):773-80. PubMed ID: 17854865
    [Abstract] [Full Text] [Related]

  • 18. Fibrinogen Cleveland II. An abnormal fibrinogen with defective release of fibrinopeptide A.
    Crum ED, Shainoff JR, Graham RC, Ratnoff OD.
    J Clin Invest; 1974 May 24; 53(5):1308-19. PubMed ID: 4856883
    [Abstract] [Full Text] [Related]

  • 19. Defective alpha-polymerization in the conversion of fibrinogen Baltimore to fibrin.
    Brown CH, Crowe MF.
    J Clin Invest; 1975 Jun 24; 55(6):1190-4. PubMed ID: 1133167
    [Abstract] [Full Text] [Related]

  • 20. Three abnormal fibrinogen variants with the same amino acid substitution (gamma 275 Arg----His): fibrinogens Bergamo II, Essen and Perugia.
    Reber P, Furlan M, Henschen A, Kaudewitz H, Barbui T, Hilgard P, Nenci GG, Berrettini M, Beck EA.
    Thromb Haemost; 1986 Dec 15; 56(3):401-6. PubMed ID: 3563970
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.